Market revenue in 2023 | USD 10.4 million |
Market revenue in 2030 | USD 18.3 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 67.31% in 2023. Horizon Databook has segmented the France biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
This country is anticipated to exhibit lucrative growth owing to an increasing number of clinical trials in the region, which requires highly equipped medical infrastructure. For instance, as of April 2023, over 5179 medical device clinical trials were registered in the country. Outsourcing medical devices leads to the optimization of resources & costs, facilitating a greater focus on innovation capabilities.
Moreover, smaller companies in this country are increasingly entering the market by offering medical devices at low prices and shifting the focus of large healthcare industry players toward innovation. Furthermore, the absence of skilled personnel and medical infrastructure for manufacturing medical devices is expected to boost the need for medical device outsourcing in this country.
All these factors are likely to improve the demand for medical device outsourcing services in the country, thereby improving the competition in the country. Some key players operating in the market are Chemineau, Thermo Fisher Scientific, and SGS SA.
Horizon Databook provides a detailed overview of country-level data and insights on the France biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into France biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account